Skip to content

Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05685914
Enrollment
200
Registered
2023-01-17
Start date
2023-05-31
Completion date
2023-08-31
Last updated
2023-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Surgery-Complications

Brief summary

The goal of this observational study is to determine 30-day mortality and post endoscopic surgery complications in patients with COVID-19 infection who undergo endoscopic surgery.This results will inform future risk stratification, decision making and improve patient's clinical care.This study is an investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk.

Interventions

PROCEDUREendoscopic surgery

Emergency or elective surgery

Sponsors

Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing any type of endoscopic surgery in an operating theatre and these patients had COVID-19 infection either at the time of surgery or within 30 days of surgery.

Exclusion criteria

* If COVID-19 infection is diagnosed \>30 days after discharge, the patient should not be included.

Design outcomes

Primary

MeasureTime frameDescription
30-day mortality30 daysDeath up to 30-days post surgery

Secondary

MeasureTime frameDescription
postoperative complications30 daysDetermine postoperative complications one month after surgery.

Countries

China

Contacts

Primary ContactLin Chang
changlin0730@126.com+86 01088196613

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026